UCSF researchers have unveiled ResMap, a robotic platform that systematically tests thousands of miniature tumors to map the hidden vulnerabilities of therapy-resistant cancer "persister" cells — a breakthrough published in Science Advances that could reshape how we fight cancer recurrence.

Plain English

When cancer drugs work, they shrink tumors fast. But a tiny fraction of cells survive treatment — as few as 1 in 1,000 tumor cells — and these "persister" cells...